OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
AXN55

Axon Vision Ltd

Aerospace & DefenseVerified

Axon Vision's capital structure is characterized by a lack of detailed liquidity metrics, as no balance-sheet inputs are available and no going-concern language is present in the source documents. This absence of data prevents a full assessment of the company's liquidity position. The valuation snapshot does not provide additional clarity on the firm's financial health or capital structure. Profitability and return metrics are not available for Axon Vision, as the valuation snapshot does not include key financial ratios such as ROIC, EBITDA margins, or net profit margins. Without these metrics, it is not possible to compare the company's performance against the industry median or to assess its efficiency in generating returns for shareholders. Axon Vision's revenue is not segmented by geographic region or business line in the available data, making it difficult to assess the company's exposure to specific markets or product lines. The lack of segment reporting limits the ability to evaluate the firm's diversification and potential concentration risks. The company's growth trajectory is also unclear, as the outlook for the current and next fiscal years does not include numeric deltas or revenue projections. Historical revenue data is not provided, which further limits the ability to assess the company's growth potential or market position. Risk factors for Axon Vision include the inability to assess liquidity risk due to the absence of balance-sheet inputs and the lack of going-concern language in the source documents. The dilution potential is currently low, as the number of shares outstanding for both basic and diluted scenarios is identical, indicating no immediate threat from share dilution. However, the absence of detailed financial data limits the ability to fully evaluate the company's risk profile. Recent events and filings for Axon Vision are not detailed in the available data, which limits the ability to assess the company's recent performance or strategic direction. The lack of transcripts or recent filings makes it difficult to evaluate management's guidance or the company's response to market conditions.

30-day price · AXN+13.90 (+1.6%)
Low$744.80High$1267.00Close$893.90As of13 May, 00:00 UTC
Profile
CompanyAxon Vision Ltd
TickerAXN.TA
SectorIndustrials
BusinessIndustrial Goods
Industry groupIndustrial Goods
IndustryAerospace & Defense
AI analysis

Business. Axon Vision Ltd is an aerospace and defense company that specializes in the design, development, and production of advanced electro-optical and infrared systems for military and commercial applications.

Classification. Axon Vision is classified under the Aerospace & Defense industry within the Industrial Goods business sector, with a confidence level of 0.92.

Axon Vision's capital structure is characterized by a lack of detailed liquidity metrics, as no balance-sheet inputs are available and no going-concern language is present in the source documents. This absence of data prevents a full assessment of the company's liquidity position. The valuation snapshot does not provide additional clarity on the firm's financial health or capital structure. Profitability and return metrics are not available for Axon Vision, as the valuation snapshot does not include key financial ratios such as ROIC, EBITDA margins, or net profit margins. Without these metrics, it is not possible to compare the company's performance against the industry median or to assess its efficiency in generating returns for shareholders. Axon Vision's revenue is not segmented by geographic region or business line in the available data, making it difficult to assess the company's exposure to specific markets or product lines. The lack of segment reporting limits the ability to evaluate the firm's diversification and potential concentration risks. The company's growth trajectory is also unclear, as the outlook for the current and next fiscal years does not include numeric deltas or revenue projections. Historical revenue data is not provided, which further limits the ability to assess the company's growth potential or market position. Risk factors for Axon Vision include the inability to assess liquidity risk due to the absence of balance-sheet inputs and the lack of going-concern language in the source documents. The dilution potential is currently low, as the number of shares outstanding for both basic and diluted scenarios is identical, indicating no immediate threat from share dilution. However, the absence of detailed financial data limits the ability to fully evaluate the company's risk profile. Recent events and filings for Axon Vision are not detailed in the available data, which limits the ability to assess the company's recent performance or strategic direction. The lack of transcripts or recent filings makes it difficult to evaluate management's guidance or the company's response to market conditions.
Key takeaways
  • Axon Vision's liquidity position cannot be assessed due to the absence of balance-sheet data and going-concern language.
  • Profitability and return metrics are not available, limiting the ability to compare the company's performance against industry benchmarks.
  • The company's geographic and segment exposure is unclear due to the lack of detailed revenue breakdowns.
  • Growth projections and historical revenue data are not provided, making it difficult to assess the company's growth potential.
  • The risk profile is constrained by the lack of detailed financial and operational data.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyILS
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4
FY-3$8.4M-$84.0k-$758.0k-$699.0k
FY-2$10.5M-$958.0k-$1.8M-$1.7M
FY-1$15.9M-$2.3M-$2.9M-$4.1M
FY0$17.4M-$8.8M-$9.4M-$10.1M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4
FY-3
FY-2$6.3M-$5.7M$2.4M
FY-1$5.7M-$8.0M$956.0k
FY0$38.5M$21.7M$24.9M
PeriodOCFCapExFCFSBC
FY-4
FY-3$277.0k-$66.0k-$699.0k
FY-2$1.0M-$31.0k-$1.7M
FY-1-$969.0k-$1.3M-$4.1M
FY0-$7.9M-$1.1M-$10.1M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Aerospace & Defense · cohort 184 companies
MetricAXNActivity
Op margin6.6% medp25 -6.7% · p75 13.4%
Net margin4.7% medp25 -6.0% · p75 11.0%
Gross margin28.0% medp25 16.8% · p75 46.8%
R&D / revenue4.1% medp25 4.1% · p75 4.1%
CapEx / revenue-6.7% medp25 -17.5% · p75 -3.2%
Debt / equity16.5% medp25 3.2% · p75 44.9%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-13 00:09 UTC#4be65313
Market quoteclose ILS 949.50 · shares 0.02B diluted
no public URL
2026-05-10 01:58 UTC#664eafee
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 10:45 UTCJob: 2cdab01d